The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans
Open accessAbstract
Chronic infection with hepatitis B virus (HBV) is associated with the majority of hepatocellular carcinoma (HCC). The diagnosis of HCC is usually made in the late stages of the disease, when treatment options are limited and prognosis is poor. We therefore have developed a method of glycoproteomic analysis in an attempt to discover serum markers that can assist in the early detection of HBV-induced liver cancer. Briefly, a comparative method for analysis of oligosaccharides released from serum glycoproteins and for recovery and identification of proteins with aberrant glycosylation, as a function of cancer diagnosis, is described. The model we have used is the woodchuck (Marmota monax), which shares similarities in the glycosylation pattern associated with liver proteins in human HCC. In this report, we show that woodchucks diagnosed with HCC have dramatically higher levels of serum-associated core α-1,6-linked fucose, as compared with woodchucks without a diagnosis of HCC. The coupling of this methodology with 2D gel proteomics has permitted the identification of several glycoproteins with altered glycosylation as a function of cancer. One such glycoprotein, Golgi Protein 73 (GP73), was found to be elevated and hyperfucosylated in animals with HCC. Further, the study showed GP73 to be elevated in the serum of people with a diagnosis of HCC, providing a validation of our approach. The potential of this technology for biomarker discovery and the implications of increased levels of GP73 in liver cancer are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Treatment of Chronic Viral Hepatitis
Hoofnagle, J. H., & Di Bisceglie, A. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701303360507 · Cited by 946
Molecular viral oncology of hepatocellular carcinoma
Block, T. M., Mehta, A. S., Fimmel, C. J., & Jordan, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206557 · Cited by 495
Self-citationNoninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics
Callewaert, N., Vlierberghe, H. V., Hecke, A. V., Laroy, W., Delanghe, J., & Contreras, R. (2004) · Nature Medicine · doi:10.1038/nm1006 · Cited by 418
El-Serag, H. B., Mason, A. C., & Key, C. (2001) · Hepatology · doi:10.1053/jhep.2001.21041 · Cited by 353
α‐Glucosidase inhibitors as potential broad based anti‐viral agents
Mehta, A., Zitzmann, N., Rudd, P. M., Block, T. M., & Dwek, R. A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00525-0 · Cited by 283
Self-citationGP73, a novel Golgi-localized protein upregulated by viral infection
Kladney, R. D., Bulla, G. A., Guo, L., Mason, A. L., Tollefson, A. E., Simon, D. J., Koutoubi, Z., & Fimmel, C. J. (2000) · Gene · doi:10.1016/s0378-1119(00)00136-0 · Cited by 276
Self-citationSu, Y.-H., Wang, M., Brenner, D. E., Ng, A., Melkonyan, H., Umansky, S., Syngal, S., & Block, T. M. (2004) · The Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60497-7 · Cited by 238
Self-citationExpression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease
Kladney, R. D., Cui, X., Bulla, G. A., Brunt, E. M., & Fimmel, C. J. (2002) · Hepatology · doi:10.1053/jhep.2002.32525 · Cited by 227
Self-citationThe α1-6-fucosyltransferase gene and its biological significance
Miyoshi, E. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00166-x · Cited by 221
Taketa, K., Sekiya, C., Namiki, M., 赤松, 興., Ohta, Y., Endo, Y., & Kosaka, K. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91034-4 · Cited by 212
Cited by
Human body fluid proteome analysis
Hu, S., Loo, J. A., & Wong, D. T. (2006) · PROTEOMICS · doi:10.1002/pmic.200600284 · Cited by 533
Liu, T., Qian, W.-J., Gritsenko, M. A., Camp, D. G., Monroe, M. E., Moore, R. J., & Smith, R. D. (2005) · Journal of Proteome Research · doi:10.1021/pr0502065 · Cited by 405
Biological Function of Fucosylation in Cancer Biology
Miyoshi, E., Moriwaki, K., & Nakagawa, T. (2007) · Journal of Biochemistry · doi:10.1093/jb/mvn011 · Cited by 395
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
Marrero, J. A., Romano, P. R., Nikolaeva, O., Steel, L., Mehta, A., Fimmel, C. J., Comunale, M. A., D'Amelio, A., Lok, A. S., & Block, T. M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.028 · Cited by 364
Self-citationGolgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
Mao, Y., Yang, H., Xu, H., Lu, X., Sang, X., Du, S., Zhao, H., Chen, W., Xu, Y., Chi, T., et al. (2010) · Gut · doi:10.1136/gut.2010.214916 · Cited by 266
Mass spectrometric analysis of N- and O-glycosylation of tissues and cells
HASLAM, S., NORTH, S., & DELL, A. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.08.006 · Cited by 111
Hoffman, M. D., Walsh, G. M., Rogalski, J. C., & Kast, J. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800230-mcp200 · Cited by 41
Storage Stability of Blood Samples for miRNAs in Glycosylated Extracellular Vesicles
Ma, C., Ding, R., Hao, K., Du, W., Xu, L., Gao, Q., & Yu, C. (2023) · Molecules · doi:10.3390/molecules29010103 · Cited by 22
“The resulting serum was carefully collected and stored at − 80 ◦ C, ensuring optimal preservation for subsequent experimental investigations.”
Background
Metadata
- Authors
- Block, T. M., Comunale, M. A., Lowman, M., Steel, L. F., Romano, P. R., Fimmel, C., Tennant, B. C., London, W. T., Evans, A. A., Blumberg, B. S., Dwek, R. A., Mattu, T. S., & Mehta, A. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-01-10
- Volume
- 102
- Issue
- 3
- Pages
- 779-784
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2099046152
- Cited by
- 372
- References
- 28
- FWCI
- 9.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.